A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country. These drugs must be approved in at least one country, from which it can be imported into the patient’s country under a NPP.

These may be drugs that are:

  • Approved but not yet commercially available to be prescribed in the patient’s country

  • Approved and available in one country but not approved and available in the patient’s country
  • Discontinued in the patient’s country but not another

  • In shortage in the patient’s country but not another

Please refer to either our Patient and Physicians or Sponsors section below for further information related to your NPP needs.

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country. These drugs must be approved in at least one country, from which it can be imported into the patient’s country under a NPP.

These may be drugs that are:

  • Approved but not yet commercially available to be prescribed in the patient’s country

  • Approved and available in one country but not approved and available in the patient’s country
  • Discontinued in the patient’s country but not another

  • In shortage in the patient’s country but not another

Please refer to either our Patient and Physicians or Sponsors section below for further information related to your NPP needs.

Patients & Physicians

Because drug companies rarely plan to make their products available in every region of the world, patients sometimes find they are unable to access certain approved medicines in their own country. Other times, patients may find that a drug they have been using is discontinued or is in shortage.

In these circumstances, patients may be able access needed drugs from another country through a NPP. To be eligible for a NPP, a patient must have a physician who is willing to prescribe the medicine on their behalf.

WEP Clinical can source products from all regions of the world and deliver them to patients and physicians in need. WEP Clinical handles all the regulatory and logistical processes involved in drug delivery and works with the patient’s physician to ensure appropriate and safe use of the drug.

If you are a patient, and you and your physician wish to gain access to an unavailable medication, please contact us at:

SPONSORS

Sponsors may only be able to focus on specific key markets when seeking approval for their drugs. Often these are well-established markets, like Europe, the US and Japan, as well as other markets which provide large patient populations.

However, sponsors could benefit from allowing access to their products in markets outside of their commercialization plans. This would allow companies to:

  • Deal with unsolicited patient request for drug in an ethical and regulatory controlled manner

  • Provide exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates

  • Provide new products to patients who would move to commercial drug when it becomes available in these countries

  • Generate additional revenues

Because there are numerous restrictions and regulations that apply on a country by country basis, providing access to medicine can be a very complex and daunting task. WEP Clinical has many years of experience helping sponsors supply their products in new regions.

If you are a sponsor and want to make your drugs available in countries where they are currently unavailable or not yet approved, please contact us at:

SPONSORS

Sponsors may only be able to focus on specific key markets when seeking approval for their drugs. Often these are well-established markets, like Europe, the US and Japan, as well as other markets which provide large patient populations.

However, sponsors could benefit from allowing access to their products in markets outside of their commercialization plans. This would allow companies to:

  • Deal with unsolicited patient request for drug in an ethical and regulatory controlled manner

  • Provide exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates

  • Provide new products to patients who would move to commercial drug when it becomes available in these countries

  • Generate additional revenues

Because there are numerous restrictions and regulations that apply on a country by country basis, providing access to medicine can be a very complex and daunting task. WEP Clinical has many years of experience helping sponsors supply their products in new regions.

If you are a sponsor and want to make your drugs available in countries where they are currently unavailable or not yet approved, please contact us at:

FAQs

Please check out our Named Patient Program FAQs page for answers to our most frequently asked sponsor and patient questions.

NEED MORE INFORMATION?